US Patent Issued to TAI BI DI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) on May 19 for "Proteolysis targeting compound with tissue targeting capability and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,579, issued on May 19, was assigned to TAI BI DI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) Co. LTD (Hebei, China).

"Proteolysis targeting compound with tissue targeting capability and use thereof" was invented by Jinxu Wang (Hebei, China), Xiangdong Su (Hebei, China) and Mingjie Bai (Hebei, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is based on the discovery of a proteolysis targeting compound having tissue targeting capability and use thereof, relating to medicinal products, and to such a compound or a pharmaceutically acceptable salt thereof, a stereoisomer, a solvate, or a polymorph. The compound is a proteolysis tar...